Representation Analysis of miRNA in Urine Microvesicles and Cell-Free Urine in Prostate Diseases
- Autores: Zaporozhchenko I.A.1,2, Bryzgunova O.E.1,2, Lekchnov E.A.1,2, Osipov I.D.3, Zaripov M.M.4, Yurchenko Y.B.1, Yarmoschuk S.V.2, Pashkovskaya O.A.2, Rykova E.Y.1,2, Zheravin A.A.2, Laktionov P.P.1,2
-
Afiliações:
- Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences
- Meshalkin Siberian Federal Biomedical Research Center
- Novosibirsk State University
- Siberian District Medical Center
- Edição: Volume 12, Nº 2 (2018)
- Páginas: 156-163
- Seção: Article
- URL: https://journals.rcsi.science/1990-7508/article/view/198203
- DOI: https://doi.org/10.1134/S1990750818020142
- ID: 198203
Citar
Resumo
Urine of prostate cancer patients contains tumor-specific biopolymers, including protein- and microvesicles-associated miRNAs that can potentially be used as oncomarkers. Previously we have characterized urinary extracellular vesicles and demonstrated diagnostic potential of their miRNAs. In this study, we have performed a comparative analysis of 84 miRNA in paired samples of urine microvesicles and urine supernatant from healthy men, patients with benign prostate hyperplasia, and prostate cancer patients using miRCURY LNA miRNA qPCR Panels. In all groups of patients, miRNA subsets characterized by different distribution between the urinary fractions have been found. In this context, two groups of miRNAs have been identified, which are involved in several signaling pathways including those associated with prostate cancer development.
Palavras-chave
Sobre autores
I. Zaporozhchenko
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Autor responsável pela correspondência
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
O. Bryzgunova
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
E. Lekchnov
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
I. Osipov
Novosibirsk State University
Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk
M. Zaripov
Siberian District Medical Center
Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk
Yu. Yurchenko
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090
S. Yarmoschuk
Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk
O. Pashkovskaya
Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk
E. Rykova
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
A. Zheravin
Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk
P. Laktionov
Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk
Arquivos suplementares
